Pacific Mercantile Bancorp Appoints Anne McCallion to Board of Directors
COSTA MESA, Calif., Sept. 21, 2020 (GLOBE NEWSWIRE) — Pacific Mercantile Bancorp (Nasdaq: PMBC, the “Company”), the holding company of […]
UMH PROPERTIES, INC. COMPLETES ACQUISITION OF NEW YORK MANUFACTURED HOUSING COMMUNITY
FREEHOLD, NJ, Sept. 21, 2020 (GLOBE NEWSWIRE) — UMH Properties, Inc. (NYSE: UMH) announced that it closed on the acquisition […]
ascena retail group Achieves Important Milestones in Restructuring Process
Court Approves Disclosure Statement and Debtor-in-Possession Financing on Final Basis; Debtor-in-Possession Financing to Convert to Exit Financing Upon EmergenceCompany to […]
Qutoutiao Inc. Reports Second Quarter 2020 Unaudited Financial Results
SHANGHAI, China, Sept. 21, 2020 (GLOBE NEWSWIRE) — Qutoutiao Inc. (“Qutoutiao”, the “Company” or “We”) (NASDAQ: QTT), a leading operator […]
Capital Senior Living Announces CFO Transition
Carey Hendrickson to Step Down on November 6, 2020Company Initiates Search for a SuccessorDALLAS, Sept. 21, 2020 (GLOBE NEWSWIRE) — […]
Delisting of Securities of Therapix Biosciences Ltd.; Stein Mart, Inc.; and Shiloh Industries, Inc. from The Nasdaq Stock Market
NEW YORK, Sept. 21, 2020 (GLOBE NEWSWIRE) — The Nasdaq Stock Market announced today that it will delist the American Depositary Shares, […]
Apellis Announces Late-Breaking Presentation of Targeted C3 Therapy Pegcetacoplan in Patients with Geographic Atrophy (GA) at EURETINA 2020
New analysis of age-related macular degeneration (AMD) progression in Phase 2 FILLY study accepted as late-breaking oral presentation at European […]
Aziyo Biologics Announces New Appointments to Board of Directors
SILVER SPRING, Md., Sept. 21, 2020 (GLOBE NEWSWIRE) — Aziyo Biologics, Inc. (“Aziyo”), a commercial-stage regenerative medicine company focused on […]
Silk Road Medical Strengthens Leadership Team
SUNNYVALE, Calif., Sept. 21, 2020 (GLOBE NEWSWIRE) — Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk […]
Dyne Therapeutics Announces Closing of Initial Public Offering
WALTHAM, Mass., Sept. 21, 2020 (GLOBE NEWSWIRE) — Dyne Therapeutics, Inc. (Nasdaq: DYN), a muscle disease company focused on advancing […]
